Patent Assignment
Reel/Frame 019111/0228
Change of Name
Recorded: 2007-04-04
Pages: 17
Assignor
VIATRIS GMBH & CO. KG
Executed: 2006-01-23
Assignee
MEDA PHARMA GMBH & CO. KG
BENZSTRASSE 1, BAD HOMBURG, 61352, GERMANY
Covered Properties
(35)
Process for the Production of 1,2-Dithiolan-3-Pentanoic Acid (Thioctic Acid) and Intermediate Compounds Therefor
Patent:
4,705,867 →
Application:
06/848,212 →
Process for the Production of 1,2-Dithiolan-3-Pentanoic Acid (Thioctic Acid) and 8-Hydrocarbylthio-6-Oxooctanoic Acid
Patent:
4,966,732 →
Application:
07/073,584 →
Process for Producing Storable Camomile Extracts Rich in Active Substances
Patent:
4,786,497 →
Application:
07/096,211 →
Salts of Azelastine Having Improved Solubility
Application:
07/519,172 →
Pharmaceutical Composition Comprising Flupirtine and Its Use to Combat Muscular Tension
Patent:
5,162,346 →
Application:
07/726,408 →
Camomile Extract Having Antimicrobial Properties, Process for Its Manufacture and Its Use
Patent:
5,244,885 →
Application:
07/820,407 →
Pharmaceutical Composition Comprising Flupirtine and Its Use to Combat Parkinson Disorders
Patent:
5,284,861 →
Application:
07/890,730 →
Camomile Oils Having a High Natural Poly-Ynes Content and Process for Their Production
Patent:
5,902,587 →
Application:
07/908,856 →
Tablets, Granulates and Pellets with a High Active Substance Content for Highly Concentrated, Solid Dosage Forms of Thioctic Acid
Patent:
5,376,382 →
Application:
08/025,053 →
Rs-Thioctic Acid with Novel Morphology
Patent:
5,455,264 →
Application:
08/134,695 →
Stable Formulation of Plant Extract
Patent:
5,389,372 →
Application:
08/149,813 →
Pharmaceutical Dosage Unit for Rectal Administration
Patent:
5,433,958 →
Application:
08/216,840 →
Salts of Azelastine Having Improved Solubility
Application:
08/281,973 →
Tablets, Granulates and Pellets with a High Active Substance Content for Highly Concentrated, Solid Dosage Forms
Patent:
5,503,845 →
Application:
08/285,145 →
Preparation for Treating Circulatory Changes
Patent:
5,532,269 →
Application:
08/320,400 →
Method for the Preparation of Hexahydroazepinones and Hexahydoazepinoles
Patent:
5,760,221 →
Application:
08/359,457 →
Tablets with Thioctic Acid of Specific Particle Size
Patent:
5,527,539 →
Application:
08/367,480 →
Use of Dl-(+/-)-Alpha-Lipoic Acid, D-(+)- Alpha- Lipoic Acid, L-(-) -Alpha-Lipoic Acid in Reduced or Oxidized Form or Salts for Treating Circulatory Disorders
Patent:
5,650,429 →
Application:
08/554,418 →
Nhe Primary and Secondary Neuroprotective Effect of Flupirtine in Neurodegenerative Diseases
Patent:
5,721,258 →
Application:
08/602,742 →
Method of Producing Flowable R,S-Thioctic Acid, R,S-Thioctic Acid and Its Use
Patent:
5,705,192 →
Application:
08/618,790 →
Salts of Azelastine Having Improved Solubility
Patent:
5,859,003 →
Application:
08/691,415 →
Use of Flupirtine for the Prophylaxis and Therapy of Diseases Associated with an Impairment of the Haematopetic Cell System
Patent:
6,034,111 →
Application:
08/744,953 →
Particulate Formulation for Administration by Inhalation
Patent:
6,284,287 →
Application:
08/765,928 →
Use of Selegiline for the Treatment of Epileptic Disorders
Patent:
5,952,388 →
Application:
08/776,931 →
Production and Use of Salts of 6,8-Bis(Amidiniumthio)-Octanoic Acid
Patent:
5,760,268 →
Application:
08/786,053 →
Use of Flupirtine for the Prophylaxis and Therapy of Disorders Which Are Associated with an Unphysiologically High Cell Death Rate
Patent:
6,124,326 →
Application:
08/873,124 →
Method Employing a Stable Preparation Containing Azelastine Hydrochloride
Patent:
6,117,864 →
Application:
08/889,807 →
Process for the Production of Lipoic Acid
Patent:
6,140,512 →
Application:
08/952,698 →
Production and Use of Salts of 6, 8-Bis (Amidiniumthio) -Octanoic Acid
Patent:
6,013,815 →
Application:
09/040,440 →
Use of Flupirtine the Prophylaxis and Therapy of Diseases Associated with an Impairment of the Haematopoetic Cell System
Patent:
6,034,112 →
Application:
09/061,099 →
Method of Producing Dry Thioctic Acid
Patent:
5,981,767 →
Application:
09/102,758 →
Salts of Azelastine Having Improved Solubility Useful at Providing a Cytoprotective Effect
Patent:
5,998,403 →
Application:
09/123,431 →
Salts of Azelastine Having Improved Solubility Effective at Treating Psoriasis and Providing a Cytopprotective Effect
Patent:
6,017,909 →
Application:
09/136,971 →
Effervescent Formulations
Patent:
6,242,002 →
Application:
09/277,393 →
Solid, Rapidly Disintegrating Cetirizine Formulations
Patent:
6,245,353 →
Application:
09/277,403 →
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 20, 1996
From: BETHGE, HORST; KLOSTERMANN, KURT; MOLLER, ROLAND; SATOR, GERHARD
To: ASTA MEDICA AKTIENGESELLSCHAFT
Reel/Frame 008114/0620 →
Assignment of Assignor's Interest
Nov 2, 2001
From: ARZNEIMITTELWERK DRESDEN GMBH
To: ASTA MEDICA AG
Reel/Frame 012295/0133 →
Change of Name
Sep 2, 2003
From: ASTA MEDICA AG
To: VIATRIS GMBH & CO. KG
Reel/Frame 014446/0444 →
Assignment of Assignor's Interest
Sep 30, 2008
From: MEDA PHARMA GMBH & CO. KG
To: EVONIK DEGUSSA GMBH
Reel/Frame 021603/0317 →